KAM
ALXN
Kazazian Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.05M | Hold |
10,701
| – | – | 1.42% | 21 |
|
|
2019
Q2 | $1.4M | Sell |
10,701
-3,184
| -23% | -$417K | 1.66% | 22 |
|
|
2019
Q1 | $1.88M | Sell |
13,885
-5,977
| -30% | -$808K | 2.61% | 14 |
|
|
2018
Q4 | $1.93M | Sell |
19,862
-9,764
| -33% | -$951K | 2.61% | 12 |
|
|
2018
Q3 | $4.12M | Buy |
29,626
+3,132
| +12% | +$435K | 3.86% | 7 |
|
|
2018
Q2 | $3.29M | Buy |
26,494
+3,211
| +14% | +$399K | 3.01% | 9 |
|
|
2018
Q1 | $2.6M | Buy |
23,283
+6,000
| +35% | +$669K | 2.72% | 10 |
|
|
2017
Q4 | $2.07M | Buy |
17,283
+6,669
| +63% | +$798K | 2.11% | 13 |
|
|
2017
Q3 | $1.49M | Buy |
10,614
+3,891
| +58% | +$546K | 1.82% | 15 |
|
|
2017
Q2 | $818K | Buy |
6,723
+2,823
| +72% | +$343K | 1.24% | 21 |
|
|
2017
Q1 | $473K | Buy |
+3,900
| New | +$473K | 0.66% | 23 |
|